Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFrontera Resources Regulatory News (FRR)

  • There is currently no data for FRR

Financing Update

7 Jun 2018 07:00

RNS Number : 5597Q
Frontera Resources Corporation
07 June 2018
 

7 June 2018

 

Frontera Resources Corporation

 

("Frontera" or "the Company")

 

Financing Update

 

Frontera Resources Corporation (AIM: FRR), the European focused oil and gas exploration and production company, today provides the following corporate finance update.

 

As announced on 18 May 2018 and described in the Shareholder Circular of the same date, on 17 May 2017 the Company entered into agreement with YA II PN, Ltd (formerly, YA Global Master SPV Ltd, an investment fund managed by Yorkville Advisors LLC) (hereinafter "YA"), whereby the entire amount of debt, which had been provided to the Company by YA under the previously announced SEDA-Backed Loan Agreement, was converted into equity by issuing to YA 7,200 Series A convertible, preferred, redeemable shares in the Company (the "Series A") with the redemption value of $1,000 per share. Over the 12-month period after their issuance, the Series A shares were convertible into a maximum of 1,300,000,000 ordinary shares of the Company. The last such conversion took place on 4 April 2018, as announced on the same date, following which YA holds the remaining 2,891 Series A shares with the redemption value of $2,891,000 which are redeemable on 16 June 2018.

 

The Company and YA have now agreed that the redemption of the remaining 2,891 Series A shares will take place over 12-month period, on a monthly basis, for which the Company will be making cash redemption payments to YA of US$265,000 per month. Once so redeemed, the Series A shares will be cancelled. The Company has also the right to convert redeemable Series A shares into ordinary shares, at its option. The Company will also have the right to pay down in cash the entire redemption amount for the outstanding number of Series A shares at any point.

 

As consideration for this agreement, the Company has agreed to issue 10,000,000 new ordinary shares in the Company ("New Ordinary Shares"), at market price, to YA II PN. Application will be made for New Ordinary Shares to be admitted to trading on AIM, which is anticipated to occur on or around 14 June 2018 ("Admission"). The New Ordinary Shares will rank pari passu with the existing Ordinary Shares of the Company. Following Admission, the Company will have 15,770,835,403 Ordinary Shares in issue with voting rights. The Company does not hold any Ordinary Shares in treasury and accordingly there are no voting rights in respect of any treasury shares. The aforementioned figure of 15,770,835,403 Ordinary Shares may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company, under the disclosure requirements applicable to the Company.

 

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

 

Enquiries:

 

Frontera Resources

(713) 585- 3216

Zaza Mamulaishvili

info@fronteraresources.com

 

Cairn Financial Advisers LLP

+44 (0) 20 7213 0880

Jo Turner / Liam Murray

 

WH Ireland Limited

+44 (0) 20 3411 1880

James Joyce / Alex Bond

 

Yellow Jersey 

+44 (0) 203 735 8825

Tim Thompson

Harriet Jackson

Henry Wilkinson

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCLLFIRRLIRIIT
Date   Source Headline
3rd Aug 20077:00 amRNSOperations Update
26th Jul 20074:02 pmRNSLoan Note Conversion
29th Jun 20077:03 amRNSDirector Purchases Shares
28th Jun 20077:04 amRNSOperations Update
28th Jun 20077:04 amRNSAnnual Report and Accounts
21st Jun 20077:01 amRNSDirector Purchases Shares
19th Jun 20077:03 amRNSDirector Purchases Shares
18th Jun 20077:01 amRNSDirector Purchases Shares
15th Jun 20077:01 amRNSOption Grant
8th Jun 20077:01 amRNSDirector Purchases Shares
7th Jun 20077:00 amRNSDirector Purchases Shares
31st May 20077:03 amRNSPrivate Placement&Final Rslts
10th May 20075:45 pmRNSFurther re Private placement
9th May 20077:02 amRNSPrivate placement
9th Jan 20077:01 amRNSBasin Edge Play Unit
3rd Jan 20077:00 amRNSWarrant Exercise
27th Dec 20067:01 amRNSWarrant Exercise
21st Dec 20067:01 amRNSWarrant Exercise
18th Dec 20067:01 amRNSTaribani Field Unit
14th Dec 20067:02 amRNSWarrant Exercise
14th Dec 20067:02 amRNSAppointment of Auditor
8th Dec 20067:01 amRNSWarrant Exercise
7th Dec 20067:02 amRNSWarrant Exercise
5th Dec 20067:02 amRNSWarrant Exercise
1st Nov 20067:01 amRNSHolding(s) in Company
9th Oct 20067:00 amRNSDirector Share Purchase
27th Sep 20067:01 amRNSDirector Share Purchase
25th Sep 20067:03 amRNSDirector Share Purchase
22nd Sep 20067:01 amRNSDirector Purchases Shares
14th Sep 20067:03 amRNSDoc re. Interim Results
14th Sep 20067:02 amRNSInterim Results
31st Aug 20067:11 amRNSIR Appointment
30th Jun 20067:01 amRNSOperations Update
29th Jun 20067:02 amRNSWarrant Exercise
29th Jun 20067:02 amRNSHoldings in Company
27th Jun 20067:00 amRNSAnnual Report and Accounts
9th Jun 20061:57 pmRNSStockholders Meeting
9th Jun 20067:00 amRNSHolding(s) in Company
31st May 20067:03 amRNSOperations News Update
30th May 20067:03 amRNSDirector Share Dealings
26th May 20067:01 amRNSShare Purchase
25th May 20067:03 amRNSOptions Exercise
17th May 20067:02 amRNSExercise of Warrants
16th May 20067:02 amRNSMeeting of Stockholders
15th May 20067:02 amRNSExercise of Warrants
10th May 20067:01 amRNSWarrent Exercise
9th May 20067:02 amRNSExercise of Warrants
5th May 20067:01 amRNSDirector Shareholding
5th May 20067:00 amRNSCrest Settlement System
28th Apr 20068:55 amRNSOption exercise

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.